Compare NUAI & CLPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NUAI | CLPT |
|---|---|---|
| Founded | N/A | 1998 |
| Country | United States | United States |
| Employees | 5 | N/A |
| Industry | Oil & Gas Production | Medical/Dental Instruments |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 403.6M | 435.7M |
| IPO Year | N/A | 2009 |
| Metric | NUAI | CLPT |
|---|---|---|
| Price | $5.25 | $12.88 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $11.00 | ★ $20.00 |
| AVG Volume (30 Days) | ★ 7.5M | 471.6K |
| Earning Date | 05-14-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $36,971,000.00 |
| Revenue This Year | N/A | $45.67 |
| Revenue Next Year | N/A | $19.51 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 17.78 |
| 52 Week Low | $0.32 | $8.27 |
| 52 Week High | $9.45 | $30.10 |
| Indicator | NUAI | CLPT |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 35.95 |
| Support Level | N/A | $12.87 |
| Resistance Level | N/A | $15.09 |
| Average True Range (ATR) | 0.00 | 0.73 |
| MACD | 0.00 | -0.20 |
| Stochastic Oscillator | 0.00 | 1.79 |
New Era Energy & Digital Inc is engaged into a fully integrated energy supplier delivering next-gen digital infrastructure and power assets. The company provides turnkey solutions to speed up data center deployment and reduce costs. The company focuses on future-proofing infrastructure for hyperscale, enterprise, and edge operators. The company provide integrated energy and digital solutions to support accelerating AI infrastructure deployment and optimize data center investments.
ClearPoint Neuro Inc is a commercial-stage medical device company that develops and commercializes integrated systems used in minimally invasive neurosurgical procedures in the brain. The company's business consists of two integrated components: a business providing medical devices for neurosurgical applications, and a business focused on partnerships in the biologics and drug delivery space. The Company operates in one reportable segment.